CN
EN
DIFF CRO
Products and Services
DIFF CRO
「DIFF CRO」 is DIFF Biotech’s CRO service platform, leveraging proprietary recombinant viral vector technologies to provide innovative solutions for antiviral drug discovery, oncolytic virus development, gene therapy research, and next-generation vaccine development. Through advanced technology platforms and translational capabilities, 「DIFF CRO」 enables partners to accelerate biomedical innovation and development.
-
Reverse Genetics Technology PlatformModular DCVL-Viraltech Architect Platform
-
Tool Virus ConstructionViral Reverse Genetics System Construction, Fluorescent Reporter Virus Construction, Pseudovirus Construction and Application Services
-
Gene Therapy Vector ConstructionAdeno-associated Virus (AAV) Vector Construction, Herpes Simplex Virus (HSV) Vector Construction
-
Oncolytic Virus Strain ConstructionNewcastle Disease Virus (NDV) Vector Oncolytic Virus Construction, Vesicular Stomatitis Virus (VSV) Vector Oncolytic Virus Construction, Herpes Simplex Virus (HSV) Vector Oncolytic Virus Construction
-
Vaccine Candidate Strain ConstructionInfluenza Virus Vaccine,Respiratory Syncytial Virus (RSV) Vaccine, Parainfluenza Virus Vaccine, Pertussis Vaccine, Rabies Virus Vaccine, Avian Influenza Virus Vaccine, African Swine Fever Virus (ASFV) Vaccine, Porcine Epidemic Diarrhea Virus (PEDV) Vaccine
-
Viral Vector ConstructionLentivirus Vector (HIV), VSV Vector, RSV Vector, NDV Vector, HMPV Vector, FHV Vector, HSV Vector